Ajax loader
By using our website, you agree to our use of cookies as described in Cookie Policy.

Can't find what you're looking for?

 

Be sure to Sign in to see all available content.

 

If you don't have an account, Register here.

Search results for:

ASTRAZENECA/
RTR2B53W
March 02, 2010
A worker leaves the AstraZeneca research facility in Loughborough, March 2, 2010. AstraZeneca is to...
Loughborough, United Kingdom
A worker leaves the AstraZeneca research facility in Loughborough
A worker leaves the AstraZeneca research facility in Loughborough, March 2, 2010. AstraZeneca is to stop researching some disease areas that form the backbone of its current business -- including schizophrenia and acid reflux -- in a drive to focus R&D efforts and cut costs. In the United States, early-stage discovery research will cease at Wilmington, Delaware, while the Swedish research site in Lund will close, as will the British site at Charnwood, as respiratory and inflammation work moves to Moelndal in Sweden. REUTERS/Darren Staples (BRITAIN - Tags: BUSINESS HEALTH EMPLOYMENT)
Sort by
Display
Items per page
Page
of 1